Inventaire - your friends and communities are your best library

The BEHAVE-AD assessment system: a perspective, a commentary on new findings, and a historical review

author

Barry Reisberg

2000 -

Carol Torossian

Stefanie Auer

Ricardo S Osorio

Sunnie Kenowsky

Jinfeng Xu

published in: Dementia and Geriatric Cognitive Disorders

date of publication: 2014

language: English

Cites articles 103

Date

Title

Authors

2014-02-20

'Residence is not home' is a particular type of delusion associated with cognitive decline of Alzheimer's disease

Kei Nakamura
2013-09-01

The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease

Howard J Aizenstein, William E. Klunk, James T Becker, Charles F Reynolds, Steven T. DeKosky
2013-01-02

A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia

Benoit H Mulsant, Patricia R Houck
2013-02-22

Equipercentile linking of the BPRS and the PANSS.

Rolf R. Engel
2013-02-22

Content of delusional thoughts in Alzheimer's disease and assessment of content-specific brain dysfunctions with BEHAVE-AD-FW and SPECT.

Kei Nakamura
2012-02-01

Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals

William J. Jagust
2010-01-01

Outcome over seven years of healthy adults with and without subjective cognitive impairment

Barry Reisberg
2010-04-01

Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment

Tobias Luck, Steffi G. Riedel-Heller, Sandra Eifflaender-Gorfer, Horst Bickel, Siegfried Weyerer, Michael Pentzek, Hanna Kaduszkiewicz, Hendrik van den Bussche, Birgitt Wiese, Wolfgang Maier, Frank Jessen, Michael Wagner, Edelgard Mösch
2009-06-10

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

Yvonne Freund-Levi, Lars-Olof Wahlund, Philip Scheltens, Harald Hampel, Hilkka Soininen, Kaj Blennow, Lennart Minthon, Magda N. Tsolaki, Frans RJ Verhey, Marcel Verbeek, Pieter Jelle Visser, Åsa K Wallin, Marcel G M Olde Rikkert, Luiza Spiru, Tuula Pirttilä, Dirk L Knol
2008-01-01

The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease

Barry Reisberg, Mony J de Leon
2008-10-01

Subjective cognitive failures and hippocampal volume in elderly with white matter lesions.
2008-02-01

Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease.

Barry Reisberg
2007-08-27

Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints

Miroslaw Brys, Mony J de Leon, Raymond P. Zinkowski
2007-06-01

Global measures: utility in defining and measuring treatment response in dementia

Barry Reisberg
2007-11-22

Mild cognitive impairment (MCI): a historical perspective.

Barry Reisberg, Steven H Ferris, Mony J de Leon, Alan Kluger
2007-03-23

Subjective memory complaints, education, and risk of Alzheimer's disease.

Albert Hofman, Monique Breteler
2006-10-01

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease

Barry D Lebowitz, T. Scott Stroup, Constantine G. Lyketsos, Jeffrey Lieberman
2006-10-01

ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions.

Steven H Ferris, Barry Reisberg, John C. Morris, Lon S Schneider, Rema Raman, Frederick A. Schmitt, Rachelle Doody
2006-04-01

Mild cognitive impairment

Barry Reisberg, Mony J de Leon, Howard Feldman, Bengt Winblad, Sylvie Belleville, Philip Scheltens, Ronald C. Petersen
2005-12-01

Risk of death in elderly users of conventional vs. atypical antipsychotic medications

Sebastian Schneeweiss, Jerry Avorn, Helen Mogun, Daniel H Solomon, M Alan Brookhart
2005-10-01

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials
2005-10-06

Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging

Steven H Ferris, Robert Cancro, Barry Reisberg
2005-10-01

Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.

Alistair Burns, Henry Brodaty
2004-12-01

Subjective memory deterioration and future dementia in people aged 65 and older.

Walter A. Kukull, Paul K. Crane, James D. Bowen, Wayne C McCormick
2004-06-01

Is MCI really just early dementia? A systematic review of conversion studies

Simon Lovestone
2003-04-01

Memantine in moderate-to-severe Alzheimer's disease

Barry Reisberg, Steven H Ferris, Frederick A. Schmitt, Rachelle Doody, Albrecht Stöffler, Hans Jörg Möbius
2003-02-01

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia

Henry Brodaty
2002-11-01

Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials
2002-07-01

Evidence and mechanisms of retrogenesis in Alzheimer's and other dementias: management and treatment import

Barry Reisberg, Stefanie Auer, Sunnie Kenowsky
2002-09-01

Are cognitively intact seniors with subjective memory loss more likely to develop dementia?
2001-01-01

Addition of a frequency-weighted score to the Behavioral Pathology in Alzheimer's Disease Rating Scale: the BEHAVE-AD-FW: methodology and reliability

Steven H Ferris, Barry Reisberg, Stefanie Auer
2001-06-01

The Alzheimer's disease activities of daily living international scale (ADL-IS).

Barry Reisberg, Mark Stemmler

Article - wd:Q27022753

Welcome to Inventaire

the library of your friends and communities

learn more